136 related articles for article (PubMed ID: 10359041)
1. Frequent p53 gene mutations in soft tissue sarcomas arising in burn scar.
Nakanishi H; Tomita Y; Yoshikawa H; Sato N; Ochi T; Aozasa K
Jpn J Cancer Res; 1999 Mar; 90(3):276-9. PubMed ID: 10359041
[TBL] [Abstract][Full Text] [Related]
2. Mutation of the p53 gene in postradiation sarcoma.
Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
[TBL] [Abstract][Full Text] [Related]
3. [Detection of point mutation of p53 gene by silver staining PCR-SSCP in paraffin-embedded malignant fibrous histiocytoma].
Li J; Yang G; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):13-5. PubMed ID: 8732103
[TBL] [Abstract][Full Text] [Related]
4. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma, malignant melanoma and malignant fibrous histiocytoma arising in burn scars.
Alconchel MD; Olivares C; Alvarez R
Br J Dermatol; 1997 Nov; 137(5):793-8. PubMed ID: 9415244
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutations in squamous cell carcinoma occurring in scars: comparison with p53 protein immunoreactivity.
Sakatani S; Kusakabe H; Kiyokane K; Suzuki K
Am J Dermatopathol; 1998 Oct; 20(5):463-7. PubMed ID: 9790106
[TBL] [Abstract][Full Text] [Related]
8. How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone?
Taubert H; Berger D; Hinze R; Meye A; Würl P; Hogendoorn PC; Holzhausen HJ; Schmidt H; Rath FW
Cancer Lett; 1998 Jan; 123(2):147-51. PubMed ID: 9489481
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of p53 and PTEN in soft tissue sarcoma.
Yin L; Liu CX; Nong WX; Chen YZ; Qi Y; Li HA; Hu WH; Sun K; Li F
Mol Med Rep; 2012 Feb; 5(2):457-61. PubMed ID: 22052239
[TBL] [Abstract][Full Text] [Related]
10. Burn scar sarcoma.
Gargan TJ; Mitchell L; Plaus W
Ann Plast Surg; 1988 May; 20(5):477-80. PubMed ID: 2837130
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar.
Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Jang JJ; Rhim KJ; Jang J; Lee HK; Park JY; Oh RR; Han SY; Lee JH; Lee JY; Yoo NJ
J Invest Dermatol; 2000 Jan; 114(1):122-6. PubMed ID: 10620127
[TBL] [Abstract][Full Text] [Related]
12. Malignant fibrous histiocytoma and squamous carcinoma derived from a burn scar.
Ozercan IH; Okur MI; Coskun F; Yildirim AM
Acta Chir Belg; 2004; 104(6):745-7. PubMed ID: 15663290
[TBL] [Abstract][Full Text] [Related]
13. An unusual long-term complication of burn injury: malignant fibrous histiocytoma developed in chronic burn scar.
Yücel A; Yazar S; Demirkesen C; Durak H; Dervişoğlu S; Altintaş M
Burns; 2000 May; 26(3):305-10. PubMed ID: 10741601
[TBL] [Abstract][Full Text] [Related]
14. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
16. Mutations of p53 tumor-suppressor gene in angiosarcoma.
Naka N; Tomita Y; Nakanishi H; Araki N; Hongyo T; Ochi T; Aozasa K
Int J Cancer; 1997 Jun; 71(6):952-5. PubMed ID: 9185695
[TBL] [Abstract][Full Text] [Related]
17. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
[TBL] [Abstract][Full Text] [Related]
18. Higher frequency of p53 gene mutations in diffuse large B-cell lymphoma with MALT component.
Tai YC; Tan JA; Peh SC
Pathol Int; 2004 Nov; 54(11):811-8. PubMed ID: 15533223
[TBL] [Abstract][Full Text] [Related]
19. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
20. p53 status in radiation-induced soft-tissue sarcomas.
Taubert H; Meye A; Bache M; Hinze R; Holzhausen HJ; Schmidt H; Rath FW; Dunst J; Würl P
Strahlenther Onkol; 1998 Aug; 174(8):427-30. PubMed ID: 9739384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]